Research
Roth Capital Initiates Coverage on Coya Therapeutics With Buy Rating, $12 Price Target
Coya Therapeutics (COYA) has an average rating of Buy and mean price target of $15.21, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$COYA
